Session » Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Biomarkers
- 1:00PM-2:30PM
-
Abstract Number: 1683
68Ga-FAPI PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 1684
Autoantibodies to Transcription Factor a Mitochondria Are Associated with Damage Accrual, Malignancy Risk and Mortality in SLE
- 1:00PM-2:30PM
-
Abstract Number: 1688
Discovery and Validation of a New Classification of ANA-RMDs That Better Predict Long Term Outcomes Compared to Legacy Diagnoses
- 1:00PM-2:30PM
-
Abstract Number: 1687
IgG and IgA anti-LIN28A Outperform Anti-dsDNA and anti-Sm in Distinguishing SLE from Health and Other Autoimmune Diseases
- 1:00PM-2:30PM
-
Abstract Number: 1685
The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Achievement of Renal Responses in Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 1686
Urine Proteomics in Class II Lupus Nephritis Reveals Immune Activation and Pro-Fibrotic Signatures